Background illustration for clinical trials search

Paid Clinical Trials Sheboygan

Discover 661 paid clinical trials in Sheboygan, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of EV for Recurrent Endometrial Carcinoma

for
Endometrial Cancer
Location: Milwaukee WI
Sponsor: William Bradley

Sex: Female

Age: 18+

Code: NCT07139977

Phase2, Recruiting

Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction

for
Laryngopharyngeal Reflux
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18 - 64

Code: NCT04383262

Phase2, Recruiting

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

for
Multiple Myeloma
Location: Milwaukee WI, Green Bay WI, Madison WI, Chicago IL,
Sponsor: European Myeloma Network B.V.

Sex: All

Age: 18+

Code: NCT05243797

Phase3, Recruiting

EMST in Patients Undergoing CRT for HNCA

for
Head and Neck Neoplasms, Deglutition Disorders
Location: Milwaukee WI
Sponsor: University of Wisconsin, Milwaukee

Sex: All

Age: 18+

Code: NCT03916809

Recruiting

Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.

for
Substance Use Disorder (SUD)
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: Female

Age: 18 - 40

Code: NCT06617949

Early_phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

for
Non-small Cell Lung Cancer,
Location: Milwaukee WI, Pittsburgh PA, Nashville TN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05877599

Phase1, Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Milwaukee WI, Chicago IL, Ann Arbor MI, Rochester MN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05850234

Phase1, Phase2, Recruiting

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Milwaukee WI, Chicago IL, Richmond VA, Atlanta GA,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT06137118

Phase1, Phase2, Recruiting

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

for
Transthyretin Amyloidosis, ATTR-CM, ATTRv-PN, ATTR, ATTR-Mixed,
Location: Milwaukee WI, Chicago IL, Rochester MN, Indianapolis IN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06465810

Recruiting

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

for
Asthma
Location: Milwaukee WI, Farmington Hills MI, Toledo OH,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06932263

Phase2, Recruiting

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

for
Multiple Sclerosis
Location: Milwaukee WI, St Louis MO, Washington D.C. DC,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 60

Code: NCT07224373

Phase1, Recruiting

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

for
Non-small Cell Lung Cancer, Colorectal Carcinoma,
Location: Milwaukee WI, Chicago IL, St Louis MO, Pittsburgh PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06218914

Phase1, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Milwaukee WI, Grand Rapids MI, Chicago IL, Rochester MN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase3, Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for
Delayed Graft Function, DGF, Kidney Transplant
Location: Milwaukee WI, Chicago IL, Ann Arbor MI, Detroit MI,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06830798

Phase3, Recruiting

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Milwaukee WI, North Chicago IL, Hinsdale IL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06350097

Phase3, Recruiting

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

for
B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL),
Location: Milwaukee WI, Chicago IL, Rochester MN, Waukee IA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06526793

Phase2, Recruiting

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

for
Polymyositis, Dermatomyositis
Location: Milwaukee WI, Willowbrook IL, Ann Arbor MI,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06455449

Phase3, Recruiting

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

for
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms,
Location: Milwaukee WI, Minneapolis MN, Centerville OH,
Sponsor: Corcept Therapeutics

Sex: Female

Age: 18+

Code: NCT06906341

Phase2, Recruiting

Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

for
Primary Membranous Nephropathy
Location: Wauwatosa WI, Hinsdale IL, Roseville MO, Edina MN,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07204275

Phase2, Phase3, Recruiting

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

for
Ulcerative Colitis, Obesity or Overweight
Location: Milwaukee WI, Chicago IL, Indianapolis IN, London,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT06937086

Phase3, Recruiting